A growing body of research in the exciting field of predictive and prescriptive analytics suggests that if you input large datasets—drawn from millions of healthcare claims or electronic medical records, for example—sophisticated algorithms can identify [read more...]

Artificial intelligence is changing healthcare. And that might include how MS will be diagnosed, treated, and managed. It's even beginning to impact the way some MS research is being conducted. Chase Spurlock, PhD, founder and [read more...]

Julia explains why she was lucky to have female role models early in her career and what she did to stay connected during her extended breaks from the workforce. She also tells us about the [read more...]

According to the American Autoimmune Related Diseases Association, autoimmune diseases are among the most prevalent diseases in the U.S., affecting approximately 50 million Americans — or 20 percent of the population. Among the 80–100 different types of autoimmune diseases [read more...]

IQuity, an integrated data-sciences company in Nashville, said it has added to its bench healthtech advisors Ray Guzman and Damian Mingle, both previously with WPC Healthcare, which recently sold to Intermedix. IQuity, led by CEO Chase Spurlock PhD, recently launched a new data analytics platform.

IQuity, a data analytics company, announced the launch of an analytics platform that uses machine learning to predict, identify, and monitor chronic disease within large populations of patients, including multiple sclerosis (MS). The platform was validated using a pilot study that assessed the healthcare claims of 20 million people in New York, which encompassed four billion data points. IQuity focused on using these data to predict the onset of MS.